急性0区壁内血肿伴最近端破口或溃疡样突起的腔内修复
回顾性分析2010年至2019年99例急性0区壁内血肿伴最近端破口或溃疡样突起的患者,比较腔内修复与开放手术的中期结果。倾向性评分匹配后,两组30天及随访死亡率无统计学显著差异,但腔内修复组手术时间、ICU停留时间和住院时间更短。作者认为,若升主动脉最大直径<50 mm且壁内血肿最大厚度<10 mm,腔内修复可作为开放手术外的选择。
要点
- 99例急性0区壁内血肿中,34例初始药物治疗,其0.5年、1年、3年无干预生存率分别为23.5%、17.6%、14.7%。
- 腔内修复组51例,1年、3年、5年生存率均为98.0%;开放手术组42例,1年、3年、5年生存率均为92.9%。
- 倾向性评分匹配后,两组30天及随访死亡率无统计学显著差异;腔内修复组手术时间69 vs 314分钟(P < .001)、ICU停留24 vs 70小时(P = .001)、住院7 vs 12天(P = .011)均更短。
核心结论
- 对于急性0区壁内血肿且最近端破口或溃疡样突起位于降主动脉的患者,除开放手术外,若升主动脉最大直径<50 mm且升主动脉壁内血肿最大厚度<10 mm,腔内修复是一种选择。
研究设计与样本
- 回顾性分析2010年1月1日至2019年12月31日急性0区壁内血肿伴最近端破口或溃疡样突起位于降主动脉的患者资料,共99例。
- 采用Kaplan-Meier曲线计算腔内或开放手术后的无干预生存率和生存率,并使用倾向性评分匹配比较腔内修复与开放手术的结果。
主要发现
- 99例患者中34例初始接受药物治疗,其0.5年、1年、3年无干预生存率分别为23.5%、17.6%、14.7%。
- 51例接受腔内治疗(其中27例在初始药物治疗后),这些患者大多升主动脉最大直径<50 mm且升主动脉壁内血肿最大厚度<10 mm;腔内修复组1年、3年、5年生存率均为98.0%。
- 42例接受开放手术(其中3例在药物治疗后),1年、3年、5年生存率均为92.9%。
- 倾向性评分匹配后,两组30天及随访死亡率无统计学显著差异;腔内修复组手术时间69 vs 314分钟(P < .001)、ICU停留时间24 vs 70小时(P = .001)、住院时间7 vs 12天(P = .011)均更短。
关键数值与推荐
- 腔内修复组1年、3年、5年生存率均为98.0%。
- 开放手术组1年、3年、5年生存率均为92.9%。
- 倾向性评分匹配后,30天及随访死亡率无统计学显著差异。
- 腔内修复组手术时间69 vs 314分钟(P < .001)。
- 腔内修复组ICU停留时间24 vs 70小时(P = .001),住院时间7 vs 12天(P = .011)。
临床怎么用
- 作者认为,对于急性0区壁内血肿且最近端破口或溃疡样突起位于降主动脉的患者,若升主动脉最大直径<50 mm且升主动脉壁内血肿最大厚度<10 mm,除开放手术外,腔内修复是一种选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the present study, we have reported the midterm results of endovascular repair of acute zone 0 intramural hematomas (IMHs) with the most proximal tear or ulcer-like projection (ULP) in the descending aorta. METHODS: Data from patients with acute zone 0 IMH with the most proximal tear or ULP in the descending aorta from January 1, 2010, to December 31, 2019, were retrospectively reviewed. We performed Kaplan-Meier curves to calculate the intervention-free survival and survival after endovascular or open surgical repair. We used propensity score matching to compare the outcomes of endovascular and open surgical repair. RESULTS: The present study included 99 patients. Of the 99 patients, 34 had initially received medical treatment. The 0.5-, 1-, and 3-year intervention-free survival rates for the 34 patients were 23.5%, 17.6%, and 14.7%, respectively. Of the 99 patients, 51 had undergone endovascular therapy, 27 after initial medical treatment. Most of these 51 patients had had a maximal diameter of the ascending aorta of <50 mm and a maximal diameter of IMH in the ascending aorta of <10 mm. The 1-, 3-, and 5-year survival rate for the endovascular group was 98.0%. Finally, 42 patients had undergone open surgery (3 after medical treatment), and the 1-, 3-, 5-year survival rates were all 92.9%. After propensity score matching, no statistically significant difference was found in the 30-day and follow-up mortality. However, endovascular repair was associated with a shorter operation time (69 vs 314 minutes; P < .001), shorter length of intensive care unit stay (24 vs 70 hours; P = .001), and shorter length of hospital stay (7 vs 12 days; P = .011). CONCLUSIONS: For patients with acute zone 0 IMH and the most proximal tear or ULP in the descending aorta, in addition to open surgery, endovascular repair is an option if the maximal diameter of the ascending aorta is <50 mm and the maximal diameter of the IMH in the ascending aorta is <10 mm.
引用
- Chen D, Luo M, Fang K, et al. Endovascular repair of acute zone 0 intramural hematoma with most proximal tear or ulcer-like projection in the descending aorta. J Vasc Surg. 2021. PMID: 34973400. doi:10.1016/j.jvs.2021.12.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。